Orexo receives paragraph IV Notice Letter for ZUBSOLV® in the US

Corporate Breaking News

Home : Orexo receives paragraph IV Notice Letter for ZUBSOLV® in the US

Aug 10 2020	Orexo receives paragraph IV Notice Letter for ZUBSOLV® in the US
UPPSALA, Sweden, Aug. 10, 2020 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces it has received a "paragraph IV" patent certification notice from Sun Pharmaceutical Industries Limited ("Sun"). The Notice Letter advises Orexo of Sun's filing of an Abbreviated...


Source:https://www.prnewswire.com:443/news-releases/orexo-receives-paragraph-iv-notice-letter-for-zubsolv-in-the-us-301108885.html

Related News
» Borr Drilling Limited Announces Appointment of Patrick Schorn as CEO » Mr. Christopher O'Connor resigns from the position of Executive Director and Chief Executive Officer of Persistent Systems Limited